Mortality After Non-ST-Segment Elevation Myocardial Infarction: Impact of Left Ventricular Function and Coronary

Nina Stødkilde-Jørgensen1, Kevin Kw Olesen2, Christine Gyldenkerne1

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

JACC. Advances
|September 17, 2025
PubMed

Insights

In patients with non-ST-segment elevation myocardial infarction (NSTEMI), both reduced left ventricular ejection fraction (LVEF) and extensive coronary artery disease (CAD) significantly increase 5-year mortality risk. This combined risk is notably higher compared to the general population.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Clinical Outcomes

Background:

  • Non-ST-segment elevation myocardial infarction (NSTEMI) is linked to coronary artery disease (CAD), potentially causing reduced left ventricular ejection fraction (LVEF) and increased mortality.
  • The combined prognostic impact of LVEF and obstructive CAD on mortality in NSTEMI patients remains under-examined.

Purpose of the Study:

  • To investigate the synergistic effect of LVEF and the extent of obstructive CAD on long-term mortality following an initial NSTEMI event.

Main Methods:

  • Analysis of 8,770 patients with first-time NSTEMI and obstructive CAD from the Western Denmark Heart Registry (2010-2021).
  • Patients stratified by LVEF categories (>50%, 41-50%, ≤40%) and coronary artery disease extent (1, 2, or 3 diseased vessels).
  • Calculation of 5-year cumulative mortality incidence, hazard ratios (HRs), and comparison with a matched general population cohort.

Main Results:

  • Five-year mortality increased progressively with decreasing LVEF and increasing CAD extent.
  • The highest mortality risk was observed in patients with LVEF ≤40% and 3-vessel disease (3VD), with a 5-year mortality of 46% (adjusted HR 3.05).
  • Patients with LVEF ≤40% and 3VD exhibited 24% higher absolute mortality compared to the general population.

Conclusions:

  • In NSTEMI patients, the combination of impaired LVEF and extensive obstructive CAD significantly predicts increased 5-year mortality.
  • These findings highlight the critical importance of assessing both LVEF and CAD burden for risk stratification in NSTEMI survivors.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
483
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
375
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828